arrow
M

Maria Cronhjort

karolinska institutet
H指数:25
被引数:3,559

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Transfusion intensity in the ICU: Reasons and triggers

ICU中的输血强度:原因和触发因素

2026-09-300
OAAI
Barriers to dispatcher-assisted CPR are associated with delayed bystander CPR and worse outcomes in out-of-hospital cardiac arrest: A retrospective cohort study

调度员辅助心肺复苏的障碍与院外心脏骤停的旁观者心肺复苏延迟及不良预后相关:一项回顾性队列研究

2026-09-110
OAAI
Albumin for Adult ICU Patients With Shock: Protocol for the INCEPT-Albumin Platform Trial Domain

白蛋白用于成人ICU休克患者的方案:INCEPT-Albumin平台试验领域

2026-02-160
OAAI
Association between red blood cell transfusion and adverse clinical outcomes is Independent of cardiac history: a multicenter observational InPUT study analysis

红细胞输注与不良临床结局之间的关联与心脏病史无关:一项多中心观察性InPUT研究的分析

2025-12-180
OAAI
Restrictive Versus Standard Intravenous Fluid Therapy and Endothelial Glycocalyx Shedding in ICU Patients With Septic Shock-A Preplanned Sub-Study of the Randomized CLASSIC Trial

限制性输液疗法与标准静脉输液疗法对脓毒症休克ICU患者血管内皮糖萼脱落的影响——CLASSIC随机试验的预先计划亚组研究

2025-12-010
OAAI
Multinational transfusion practices and outcomes in haematology patients admitted to the intensive care unit

多国输血实践与入住重症监护病房的血液病患者的结局

2025-11-010
OAAI
Global transfusion practices in septic patients in the intensive care unit: insights from the InPUT-study sub-analysis

重症监护病房脓毒症患者的全球输血实践:InPUT-study子分析的见解

2025-10-220
OAAI
Effects of restrictive fluid therapy on the time to resolution of hyperlactatemia in ICU patients with septic shock. A secondary post hoc analysis of the CLASSIC randomized trial

限制性液体治疗对ICU脓毒症休克患者高乳酸血症消退时间的影响。经典随机试验的二次事后分析

2024-04-105
OAAI
Red Blood Cell Transfusion in the Intensive Care Unit

重症监护病房的红细胞输注

2023-11-2116
OA
Long-term effects of restriction of intravenous fluid in adult ICU patients with septic shock

限制静脉补液对ICU成人脓毒症休克患者的长期影响

2023-06-1814
OAAI
Atrial Fibrillation (AFIB) in the ICU: Incidence, Risk Factors, and Outcomes: The International AFIB-ICU Cohort Study*

ICU中的心房颤动 (AFIB): 发病率,危险因素和结果: 国际AFIB-ICU队列研究 *

2023-04-2012
OA
Effects of 12 mg vs. 6 mg dexamethasone on thromboembolism and bleeding in patients with critical COVID-19-a post hoc analysis of the randomized, blinded COVID STEROID 2 trial
2023-03-021
OAAI